Ramcharan, Roger <br/><br/>
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide.  [electronic resource] 

 -  Oncotarget  Nov 2015 
 - 39877-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.5631  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>DNA Breaks, Double-Stranded--drug effects<br/>Dacarbazine--administration & dosage<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Imidazoles--administration & dosage<br/>Melanoma--drug therapy<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mutation<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyrazines--administration & dosage<br/>Receptor, IGF Type 1--antagonists & inhibitors<br/>Survival Analysis<br/>Temozolomide<br/>Tumor Suppressor Protein p53--genetics<br/>Xenograft Model Antitumor Assays